Pfizer CEO Albert Bourla told The Times of Israel that a COVID-19 vaccine could be ready around October-end. "If things go well...we will have enough evidence of safety and efficacy so that we can…have a vaccine around end of October," Bourla said. Earlier, Pfizer had announced that it had begun testing its experimental COVID-19 vaccine on humans in US.